classic
swine
fever
csf
highli
contagi
viral
diseas
pig
caus
major
econom
loss
worldwid
specif
drug
current
avail
effect
treatment
csfv
infect
howev
rna
interfer
rnai
appli
success
inhibit
replic
human
anim
virus
studi
three
effect
sirna
target
csfv
select
target
gene
chosen
experiment
target
n
pro
gene
target
gene
describ
previous
singl
doubl
quadrupl
anticsfv
sirna
express
plasmid
loxp
site
end
select
marker
gene
construct
analyz
use
promot
four
differ
promot
target
n
pro
gene
csfv
result
indic
singl
multipl
sirna
express
plasmid
effici
inhibit
csfv
replic
inhibit
markedli
stronger
multipl
sirna
express
target
differ
gene
csfv
sinc
rnai
appli
anticsfv
research
studi
provid
anticsfv
method
singl
multipl
sirna
express
target
viral
isol
differ
subtyp
prevent
viral
escap
also
provid
basi
develop
csfvresist
transgen
pig
rna
interfer
rnai
natur
posttranscript
gene
silenc
mechan
appli
success
inhibit
replic
human
anim
virus
human
immunodefici
viru
type
sarscov
wu
et
al
influenza
viru
sui
et
al
footandmouth
diseas
viru
chen
et
al
porcin
reproduct
respiratori
syndrom
viru
li
et
al
classic
swine
fever
viru
xu
et
al
vitro
vivo
classic
swine
fever
csf
highli
contagi
diseas
pig
caus
infect
csfv
notifi
diseas
world
organ
anim
health
oie
csf
caus
great
econom
loss
pig
industri
worldwid
diseas
first
recogn
china
continu
major
epizoot
countri
tu
et
al
zhu
et
al
csfv
belong
genu
pestiviru
famili
flavivirida
genom
consist
singlestrand
sens
rna
kb
singl
larg
open
read
frame
orf
encod
polyprotein
approxim
amino
acid
translat
polyprotein
cleav
viral
structur
nonstructur
peptid
nto
cterminu
n
pro
ce
ms
n
pro
essenti
evad
cellular
antivir
defens
system
protect
cell
doublestrand
rnainduc
apoptosi
ruggli
et
al
serin
proteas
cleav
downstream
cleavag
site
tautz
et
al
tautz
et
al
addit
possess
helicas
ntpase
activ
essenti
viral
rna
replic
gu
et
al
moulin
et
al
rnadepend
rna
polymeras
respons
viral
rna
replic
zhang
et
al
previou
studi
vitro
transcrib
sirna
molecul
xu
et
al
retroviralmedi
rnai
li
et
al
show
rnai
capabl
specif
effici
inhibit
csfv
replic
one
problem
sirna
entir
inhibit
csfv
replic
suggest
due
loss
sirna
activ
caus
point
mutat
delet
sirna
target
site
konishi
et
al
westerhout
et
al
studi
singl
doubl
quadrupl
anticsfv
sirna
express
plasmid
loxp
site
end
select
marker
gene
construct
analyz
use
promot
four
differ
promot
four
differ
sirna
express
four
differ
promot
avoid
recombin
result
show
csfv
inhibit
markedli
stronger
multipl
sirna
express
target
differ
gene
csfv
sirna
target
region
mutat
major
reason
csfv
replic
complet
block
rnai
also
see
front
matter
elsevi
bv
right
reserv
provid
basi
develop
csfvresist
transgen
pig
reason
sirna
express
plasmid
construct
loxp
site
end
select
marker
gene
could
excis
cremedi
loxpflank
sequenc
pig
kidney
cell
line
passag
virul
csfv
strain
shimen
obtain
institut
veterinari
drug
control
china
mab
kindli
provid
dr
trevor
drew
veterinari
laboratori
agenc
weybridg
uk
rais
csfv
strain
edward
sand
paton
et
al
affin
protein
gener
ascit
fluid
balbc
mice
screen
sirna
target
gene
sirna
duplex
sirna
design
synthes
shanghai
genechem
co
ltd
shanghai
china
symmetr
overhang
target
sequenc
gcu
uau
gag
ugg
aau
aca
auu
nucleotid
csfv
genom
genbank
access
gau
gcc
aca
acc
uaa
guu
auu
nucleotid
cca
cua
uga
ucu
acu
gca
auu
nucleotid
respect
neg
control
sirna
synthes
target
sequenc
uuc
ucc
gaa
cgu
guc
acg
uuu
match
either
viral
porcin
genom
cell
monolay
confluent
sirna
introduc
use
xtremegen
sirna
transfect
reagent
roch
indianapoli
accord
manufactur
protocol
sirna
final
concentr
nm
sirnatransfect
cell
infect
ccid
csfv
cultur
h
indirect
immunofluoresc
assay
ifa
detect
copi
number
csfv
genom
rna
detect
infecti
viru
product
perform
describ
previous
li
et
al
singl
doubl
sirna
express
plasmid
construct
three
candid
sequenc
design
describ
previous
xu
et
al
chosen
sirna
n
pro
gene
describ
chosen
sirna
gene
sequenc
select
neg
sirna
control
sic
xu
et
al
oligonucleotid
synthes
sequenc
nanj
genscript
co
ltd
nanj
china
tabl
oligonucleotid
anneal
ligat
hindiii
site
psilenc
ambion
austin
tx
obtain
plasmid
sirna
sirna
repres
sic
sirna
amplifi
pcr
use
plasmid
templat
follow
primer
tabl
sirna
digest
ligat
appropri
insert
site
addgen
plasmid
form
plasmid
plox
sirna
see
fig
c
insert
sequenc
confirm
shanghai
sangon
biolog
engin
technolog
servic
co
shanghai
china
construct
express
plasmid
base
pgenesil
genesil
biotechnolog
co
wuhan
china
respect
contain
human
murin
human
human
polymeras
iii
promot
renam
first
sirna
express
plasmid
construct
insert
anneal
oligonucleotid
appropri
insert
site
therebi
encod
sirna
transcript
unit
second
plasmid
construct
differ
sirna
express
plasmid
genesil
biotechnolog
co
final
sirna
cassett
digest
insert
salixhoi
site
yield
see
fig
n
pro
nucleotid
csfv
genom
nucleotid
nucleotid
amplifi
pcr
use
primer
n
pro
fw
n
pro
rev
tabl
product
digest
ligat
xhoipsti
site
clontech
mountain
view
ca
form
plasmid
pegfpn
pro
cotransfect
report
doubl
sirna
express
plasmid
cell
confluenc
plate
cotransfect
lg
fusion
report
plasmid
doubl
sirna
express
plasmid
control
plasmid
ploxsic
hd
transfect
reagent
accord
manufactur
protocol
infect
ccid
csfv
cultur
h
indirect
immunofluoresc
assay
ifa
detect
csfv
genom
copi
number
detect
infecti
viru
product
perform
describ
previous
li
et
al
analysi
csfv
escap
rna
interfer
ploxsirna
linear
kpni
saci
use
transfect
cell
lgml
gibco
cell
deriv
singl
cell
cultur
screen
stabl
sirna
express
posit
cell
examin
ifa
inhibit
csfv
replic
infect
csfv
stabl
sirnaexpress
cell
use
seed
ml
cell
cultur
tube
nunc
rochest
ny
incub
ccid
csfv
mem
h
fb
contain
lgml
h
tube
freezethaw
three
time
viruscontain
supernat
store
use
use
procedur
total
passag
carri
transfer
ml
supernat
previou
passag
sirna
target
sequenc
passag
supernat
amplifi
pcr
use
primer
list
tabl
sequenc
confirm
shanghai
sangon
biolog
engin
technolog
servic
co
shanghai
china
total
rna
isol
use
trizol
reagent
invitrogen
carlsbad
ca
quickgen
rna
cell
cultur
cell
hc
kit
fujifilm
japan
accord
manufactur
protocol
numer
paramet
includ
genom
copi
viral
titer
express
mean
standard
deviat
student
ttest
use
analysi
numer
paramet
spss
window
spcc
inc
calcul
p
valu
studi
inhibitori
effect
three
sirna
target
gene
csfv
replic
level
viral
antigen
viral
genom
copi
number
product
viabl
viru
cell
sirna
transfect
csfv
infect
examin
h
postcsfv
infect
cell
display
green
fluoresc
compar
control
fig
viral
genom
copi
number
significantli
decreas
cell
receiv
p
p
p
fig
product
viabl
viru
significantli
decreas
cell
transfect
p
p
p
fig
result
indic
three
sirna
effect
inhibitor
csfv
replic
especi
therefor
chosen
experiment
cell
cultur
cotransfect
multipl
sirna
express
plasmid
egfp
report
contain
csfv
target
sequenc
describ
egfp
express
level
reduc
sirna
match
report
data
shown
confirm
observ
inhibit
csfv
replic
occur
sequencespecif
mechan
similar
result
obtain
multipl
sirna
express
plasmid
match
report
fig
data
show
sirna
still
function
two
four
differ
sirna
express
within
singl
vector
use
ifa
mab
level
viral
antigen
determin
follow
csfv
infect
cell
transfect
singl
multipl
sirna
express
plasmid
h
postcsfv
infect
cell
express
sic
exhibit
bright
green
fluoresc
cytoplasm
indic
cell
control
produc
viru
fig
contrast
small
proport
cell
receiv
singl
multipl
sirna
express
plasmid
display
green
fluoresc
indic
cell
effect
protect
sirna
fig
addit
level
protect
enhanc
multipl
sirna
express
especi
target
differ
gene
csfv
viral
genom
copi
number
determin
realtim
pcr
stratagen
use
serial
dilut
plasmid
utr
standard
r
valu
standard
curv
averag
amplif
effici
e
sequenc
product
show
expect
part
utr
gene
therebi
demonstr
specif
reliabl
analysi
data
indic
realtim
pcr
highli
reliabl
assay
copi
number
viral
genom
significantli
decreas
cell
express
singl
multipl
sirna
compar
sic
cell
p
fig
viral
genom
copi
number
also
significantli
decreas
cell
express
compar
express
singl
sirna
plasmid
p
indic
inhibit
effici
enhanc
multipl
sirna
target
differ
gene
csfv
measur
ccid
assay
product
viabl
viru
decreas
cell
express
singl
multipl
sirna
compar
sic
cell
fig
product
viabl
viru
also
significantli
decreas
cell
express
singl
sirna
p
show
multipl
sirna
express
target
differ
gene
csfv
provid
effect
inhibit
genet
stabil
csfv
expos
rna
interfer
investig
csfv
could
develop
resist
rnai
growth
studi
carri
stabl
sirnaexpress
cell
ten
line
cell
infect
csfv
passag
time
viral
genom
line
passag
sequenc
sirna
target
region
compar
correspond
region
parent
viru
genom
mutat
detect
data
shown
csfv
genom
singlestrand
rna
function
messeng
rna
replic
templat
make
attract
target
studi
rna
interfer
success
rna
interfer
inhibit
csfv
replic
alreadi
demonstr
synthet
sirna
xu
et
al
retrovir
vectormedi
sirna
target
n
pro
gene
li
et
al
knowledg
sirna
target
gene
csfv
report
possess
serin
proteas
helicas
ntpase
activ
essenti
viral
rna
replic
korf
et
al
report
inhibit
hcv
gene
sirna
present
studi
three
sirna
target
gene
csfv
effect
inhibit
csfv
replic
effect
reduct
titer
provid
candid
target
site
explor
new
approach
prevent
csf
develop
effect
rnaibas
gene
silenc
csfv
simpl
strategi
would
express
multipl
sirna
singl
multipl
promot
one
vector
saayman
et
al
ter
brake
et
al
ter
brake
et
al
previou
studi
perform
analysi
multipl
sirna
express
strategi
three
four
sirna
express
promot
found
caus
frequent
recombin
repeat
sequenc
express
cassett
result
delet
one
two
cassett
prevent
recombin
therefor
select
four
differ
promot
lack
sequenc
similar
four
sirna
express
strategi
human
polymeras
iii
promot
murin
polymeras
iii
promot
select
well
defin
transcript
start
termin
site
clone
target
sequenc
upstream
report
gene
simpl
conveni
method
examin
whether
sirna
transcript
occur
multipl
express
plasmid
fig
show
sirna
express
cassett
activ
confirm
multipl
sirna
express
promot
valid
approach
vector
express
sirna
cell
multipl
sirna
express
inhibit
csfv
replic
much
effect
singl
sirna
observ
consist
previou
report
multipl
sirna
target
mrna
result
enhanc
gene
silenc
ji
et
al
reduct
viral
genom
copi
number
viabl
viru
product
h
postcsfv
infect
multipl
sirna
express
indic
effect
inhibit
csfv
replic
addit
maintain
cumul
effect
may
restrict
optim
shrna
process
limit
cellular
compon
rnai
machineri
castanotto
et
al
might
explain
sirna
express
level
reduc
compar
singl
sirna
express
vector
measur
northern
blot
ter
brake
et
al
viral
replic
complet
block
combin
express
multipl
sirna
surpris
sinc
rnai
target
incom
genom
viru
replic
may
still
occur
therefor
albeit
low
level
perhap
slowli
accumul
certain
threshold
reach
viru
escap
result
longterm
exposur
antivir
rnai
observ
sever
studi
da
et
al
gitlin
et
al
konishi
et
al
present
studi
howev
mutat
target
site
detect
even
tenth
viru
passag
sirnaexpress
cell
result
indic
target
site
mutat
major
reason
csfv
replic
complet
block
rnai
creloxp
dna
recombinas
system
develop
power
tool
manipul
dna
vitro
vivo
guo
et
al
li
et
al
schmidt
et
al
mani
transgen
mous
model
establish
use
creloxp
technolog
chen
et
al
lin
et
al
li
et
al
creat
egfp
report
transgen
pig
appli
creloxp
recombinas
system
anticsfv
activ
rnai
combin
technolog
produc
transgen
pig
result
could
pig
resist
csfv
infect
reason
construct
singl
multipl
anticsfv
sirna
express
plasmid
loxp
site
end
select
marker
gene
genom
copi
number
mean
three
experi
viral
genom
copi
number
per
nanogram
total
rna
sictransfect
cell
calcul
standard
curv
ng
ng
h
postcsfv
infect
respect
nineti
five
percent
confid
interv
shown
p
p
fig
inhibit
viabl
viral
product
cell
transfect
singl
multipl
sirna
express
plasmid
h
postcsfv
infect
ccid
valu
calcul
method
ccid
mean
three
repeat
titrat
time
point
indic
viabl
viral
product
sictransfect
cell
ccid
ml
ccid
ml
h
postcsfv
infect
respect
nineti
five
percent
confid
interv
shown
p
p
